IV Vitamin C Therapy in Cancer Care
Intravenous high-dose ascorbic acid achieves plasma concentrations 30–70 times higher than oral supplementation. In integrative oncology, it is used to support immune function, reduce cancer-related fatigue, and improve quality of life during and after conventional cancer treatment.
What Is IV Vitamin C Therapy?
IV vitamin C therapy involves administering high-dose ascorbic acid intravenously, achieving plasma concentrations far beyond what is possible with oral supplementation. In integrative oncology, it is prescribed to support immune function, reduce cancer-related fatigue, and improve quality of life — used alongside, not instead of, conventional cancer treatment.
At supraphysiological doses, ascorbic acid acts as a pro-oxidant rather than an antioxidant. It generates hydrogen peroxide selectively in tumour tissue, where catalase activity is lower than in normal cells. This selective cytotoxicity is the basis for its investigation as an adjunct to conventional cancer treatment in Phase I and II clinical trials.
The National Cancer Institute (NCI) has reviewed the evidence for IV vitamin C in cancer care and acknowledges its use in integrative oncology settings. Multiple Phase I and II trials have demonstrated safety and tolerability, with improvements in quality of life and fatigue as the most consistently reported outcomes.
Mechanism of Action
At pharmacological doses (typically 25–100g per infusion), ascorbic acid acts as a pro-oxidant. It donates electrons to metal ions (iron, copper) in the extracellular fluid, generating hydrogen peroxide (H₂O₂). Normal cells have sufficient catalase to neutralise this H₂O₂; tumour cells, which have lower catalase activity, are more susceptible to oxidative damage. This selective mechanism is distinct from the antioxidant properties of oral vitamin C at physiological doses.
Additionally, IV vitamin C supports collagen synthesis (important for tissue repair after surgery or radiotherapy), modulates inflammatory cytokines, and supports adrenal function — all of which contribute to the fatigue and wellbeing improvements observed clinically.
Safety, Contraindications, and Drug Interactions
IV vitamin C is generally well tolerated. The most important contraindication is glucose-6-phosphate dehydrogenase (G6PD) deficiency — a genetic condition that affects red blood cell stability. In G6PD-deficient patients, high-dose IV vitamin C can cause haemolytic anaemia. A G6PD blood test is mandatory before the first infusion.
Caution is required in patients with renal impairment, haemochromatosis, and those on certain chemotherapy agents. The interaction between IV vitamin C and radiotherapy is complex — some evidence suggests it may reduce radiotherapy efficacy at certain doses and timings. Dr Kloppenburg does not prescribe IV vitamin C concurrently with radiotherapy without oncologist communication.
G6PD deficiency screening is required before IV vitamin C can be prescribed. This is a standard blood test that Dr Kloppenburg arranges as part of the pre-treatment assessment.
Clinical Evidence for IV Vitamin C in Cancer Care
The following summarises the key clinical outcomes supported by the current evidence base for high-dose intravenous ascorbic acid in oncology.
| Clinical Outcome | Evidence Level | Key Sources |
|---|---|---|
| Quality of life improvement | Moderate — Phase I/II trials and observational studies | Padayatty et al.; Carr & Cook 2018 |
| Cancer-related fatigue reduction | Moderate — multiple clinical studies | Vollbracht et al.; Mikirova et al. |
| Safety and tolerability | Strong — established across multiple trials | NCI review; Hoffer et al. |
| Chemotherapy enhancement (in vitro) | Preliminary — Phase I/II trials ongoing | Ma et al.; Polireddy et al. |
| Direct anti-tumour effect (clinical) | Insufficient — in vitro and animal data only | Not a basis for clinical prescribing |
| Radiotherapy interaction | Uncertain — conflicting data | Not co-prescribed without oncologist review |
Frequently asked questions
Questions About IV Vitamin C Therapy
What is IV vitamin C therapy and how is it used in cancer care?
Intravenous (IV) vitamin C therapy involves administering high-dose ascorbic acid directly into the bloodstream via an infusion. At high doses, vitamin C acts as a pro-oxidant, generating hydrogen peroxide in tumour tissue. In integrative oncology, it is used to support immune function, reduce cancer-related fatigue, and improve quality of life during and after conventional treatment.
Is IV vitamin C different from oral vitamin C supplements?
Yes. Oral vitamin C is absorbed through the gut and the body regulates plasma levels tightly — typically reaching a maximum of around 200 micromol/L. Intravenous administration bypasses this regulation, achieving plasma levels 30–70 times higher. These supraphysiological concentrations are required for the pro-oxidant and immune-supporting effects observed in clinical studies.
Can IV vitamin C be used during chemotherapy?
This depends on the specific chemotherapy agent. Some studies suggest IV vitamin C may enhance the efficacy of certain chemotherapy drugs; others raise concerns about potential antioxidant interference. Dr Kloppenburg reviews your full oncology protocol before prescribing IV vitamin C. She does not prescribe it during radiotherapy without oncologist communication.
Who should not receive IV vitamin C therapy?
IV vitamin C is contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, as it can cause haemolytic anaemia. It requires caution in patients with renal impairment and those with haemochromatosis. A G6PD blood test is required before the first infusion. Dr Kloppenburg screens all patients before prescribing.
How do I access IV vitamin C therapy through Dr Kloppenburg?
Book a 60-minute remote consultation by calling 07575 424024 or completing the online request form. Dr Kloppenburg will review your medical history, current treatment, and blood results before prescribing. You will receive a written care plan including infusion protocol and safety guidance.
Discuss IV Vitamin C Therapy with Dr Kloppenburg
Book a 60-minute remote consultation to discuss whether IV vitamin C therapy is appropriate for your situation. Dr Kloppenburg will review your oncology protocol and arrange pre-treatment blood tests.
Remote consultations · UK-wide · 60 minutes · Book via call or online request